Abstract
The suitability of 200 consecutive patients admitted to a newly established acute stroke unit was assessed for participation in two multicentre trials currently in their pilot phase: the International Stroke Trial of aspirin and heparin, and the Multicentre Acute Stroke Trial of streptokinase versus placebo. Of the 200 patients (74 men, 126 women, mean age 71 years), 96% had cerebral CT, and 94% had a final diagnosis of cerebrovascular disease. Overall, 50% of patients presented within 6 hours and 70% within 12 hours of the onset of ictus. A total of 113 patients (56.5%) were potentially eligible for trial treatment with aspirin/heparin. Only 9 patients (4.5%) were eligible for streptokinase treatment: 50% were excluded because they presented after 6 hours; 23% had a previous stroke with clinical sequelae and 23% had severe systemic illness. Forty eight per cent of patients had more than one exclusion criterion. The potentially high enrollment rates in trials of antithrombotic agents contrast with the restricted recruitment for trials of streptokinase, emphasising the need for multiple centres to achieve useful study enrollment.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bamford J., Sandercock P., Dennis M., Burn J., Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991 Jun 22;337(8756):1521–1526. doi: 10.1016/0140-6736(91)93206-o. [DOI] [PubMed] [Google Scholar]
- Barsan W. G., Brott T. G., Olinger C. P., Marler J. R. Early treatment for acute ischemic stroke. Ann Intern Med. 1989 Sep 15;111(6):449–451. doi: 10.7326/0003-4819-111-6-449. [DOI] [PubMed] [Google Scholar]
- Duke R. J., Bloch R. F., Turpie A. G., Trebilcock R., Bayer N. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med. 1986 Dec;105(6):825–828. doi: 10.7326/0003-4819-105-6-825. [DOI] [PubMed] [Google Scholar]
- Gelmers H. J., Gorter K., de Weerdt C. J., Wiezer H. J. A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med. 1988 Jan 28;318(4):203–207. doi: 10.1056/NEJM198801283180402. [DOI] [PubMed] [Google Scholar]
- LaRue L. J., Alter M., Traven N. D., Sterman A. B., Sobel E., Kleiner J. Acute stroke therapy trials: problems in patient accrual. Stroke. 1988 Aug;19(8):950–954. doi: 10.1161/01.str.19.8.950. [DOI] [PubMed] [Google Scholar]
- Martínez-Vila E., Guillén F., Villanueva J. A., Matías-Guiu J., Bigorra J., Gil P., Carbonell A., Martínez-Lage J. M. Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction. Stroke. 1990 Jul;21(7):1023–1028. doi: 10.1161/01.str.21.7.1023. [DOI] [PubMed] [Google Scholar]
- Norris J. W., Hachinski V. C. High dose steroid treatment in cerebral infarction. Br Med J (Clin Res Ed) 1986 Jan 4;292(6512):21–23. doi: 10.1136/bmj.292.6512.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steiner T. J., Clifford Rose F. Towards a model stroke trial. The single-centre naftidrofuryl study. Neuroepidemiology. 1986;5(3):121–147. doi: 10.1159/000110823. [DOI] [PubMed] [Google Scholar]
- del Zoppo G. J., Ferbert A., Otis S., Brückmann H., Hacke W., Zyroff J., Harker L. A., Zeumer H. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke. 1988 Mar;19(3):307–313. doi: 10.1161/01.str.19.3.307. [DOI] [PubMed] [Google Scholar]